Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Chloroquine phosphate
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/27/2021
Hydroxychloroquine sulfate
Potential treatment - clinical evidence Used to treat other disease Antiviral Apr/27/2021
8-{3-hydroxy-4-[(7-hydroxynaphthalen-2-yl)oxy]phenoxy}-1,4-benzodioxin-5-ol
Potential treatment - theoretical effect Experimental Antiviral Apr/25/2021
Naphthazarin
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/24/2021
Menadione
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/24/2021
CA521FALA
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
WNbFc 36
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
WNbFc 15
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
WNbFc 7
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
WNbFc 2
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/23/2021
TPNT1
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/22/2021
Anacardic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Sciadopitysin
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Ginkgo biloba leaves extract
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Ginkgolic acid C17:1
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021
Camostat mesylate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Apr/22/2021
Ambroxol
Potential treatment - pre-clinical evidence Natural product Other treatment Apr/22/2021
Reduning
Potential treatment - clinical evidence Natural product Antiviral Apr/22/2021
Lopinavir
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Apr/22/2021
Baicalein
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/22/2021